Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease

Not Applicable

Completed

• Conditions: Arteriosclerosis; Coronary Artery Disease; Angina Pectoris; Myocardial Ischemia
• Interventions: Procedure: Cardiac MRI; Procedure: SPECT

• Registration Number: NCT02264717
• Lead Sponsor: University of Aarhus

Brief Summary

1. The primary purpose of this study is to determine the diagnostic accuracy of the CADscore System, a new danish technology that records sounds from turbulence of bloodflow in the coronary vessels.

And secondary:

1. To determine the accuracy of cardiac magnetic resonance imaging (MRI) and single-photon emission computed tomography (SPECT), as secondary tests after detection of obstructive anatomic coronary artery stenosis by coronary computed tomographic angiography (CCTA).

2. To examine the patient population for bio-genetic markers related to development of arteriosclerosis.

3. To evaluate virtual fractional flow reserve (vFFR) computed from coronary angiograms.

Detailed Description

Primary study CCTA is currently the first choice to rule out coronary artery disease (CAD) in patients with typical or atypical chest pain. 4500 patients are annually examined with CCTA, in the Central Jutland Region of Denmark, and approximately 80% are discharged after ruling out CAD. CCTA is a diagnostic scan that exposes the patients to radiation, therefore a better risk stratification prior to the test is desirable. The CADscore is a newly developed danish technology that has been tested so far in 1000 patients. An area under the curve of the receiver operating characteristic (AUC of ROC) of 75-80 has been determined compared to conventional coronary angiography using quantitative coronary angiography (CCA-QCA). This indicates that the CADscore could potentially be used to diagnose CAD as a supplement or risk stratification prior to CCTA.

We aim to evaluate the CADscore in a large clinical trial including 2000 patients that by clinical indication undergo cCTA. After cCTA approximately 20 % (400 patients) will need evaluation by CCA with FFR. CADscore results will be compared to CCTA and CCA-QCA. Secondary, the CADscore will be compared to the results of CCA-FFR and perfusion scans, Cardiac-MRI and SPECT.

Substudies

1. Perfusion scans

CCTA demonstrates good diagnostic performance for detection and exclusion of anatomic coronary artery stenosis, but several studies have previously shown that CCTA has a low positive predictive value for identification of hemodynamically significant CAD. This emphasizes the need for additional tests to evaluate the severity (or exclusion) of hemodynamically significant CAD. Measurement of FFR during CCA represents the "gold standard" for assessment of the hemodynamic significance of coronary artery stenosis. The disadvantage of CCA with FFR is that it is an invasive procedure.

After cCTA approximately 20 % (400 patients) will need further testing and that group of patients will be randomized to either Cardiac MRI or SPECT followed by CCA with FFR.

The substudy aims to evaluate the diagnostic accuracy of perfusion imaging (Cardiac MRI and SPECT) compared with CCA with FFR.

2. Virtual FFR

The accuracy and precision of virtual-FFR compared with conventional FFR will be determined. Virtual FFR is computed from the coronary angiogram using computational fluid dynamics. Subjects with diameter stenosis in the range of 30 to 90% by visual estimate in one or more vessel segments with reference diameter ≥2.0 mm will be included in the analysis. FFR is the reference standard to determine the presence or absence of hemodynamically significant obstruction with a cut-off value of 0.80. Computation of vFFR with and without hyperaemia will be compared.

Study Timeline

• Study Start: 2014-09
• Study First Submitted: 2014-09-26
• Study First Submitted QC: 2014-10-09
• Study First Posted: 2014-10-15
• Status Verified: 2015-05
• Primary Completion: 2016-05
• Study Completion: 2016-05
• Last Update Submitted: 2016-05-12
• Last Update Posted: 2016-05-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1676

Inclusion Criteria

• Indication for Cardiac CT
• Signed

Read More

Exclusion Criteria

• Age under 40
• Pregnant, potentially pregnant or breast feeding
• Contraindication for adenosine (severe asthma, clinical aortic stenosis)
• Reduced kidney function (eGFR < 40 ml/min)
• Contraindication for MRI
• Previous history of allergy to contrast
• Previous revascularisation procedure

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Cardiac MRi	Cardiac MRI	A minimum of 150 patients will be randomized to Cardiac MRI followed by conventional angiography CCA-FFR, after detection of obstructive anatomic coronary artery stenoses on coronary Computed Tomography Angiography (cCTA)
SPECT	SPECT	A minimum 150 patients will be randomized to SPECT followed by conventional angiography CCA-FFR, after detection of obstructive anatomic coronary artery stenoses on coronary Computed Tomography Angiography (cCTA).

Primary Outcome Measures

Name	Time	Method
Diagnostic accuracy of the CADscore system compared to CCTA and CCA-QCA.	Within one week before or after CCTA	Diagnostic precision will be evaluated as the AUC-ROC. The CADscore will be dichotomized at cut off values of 20,25 and 30 and performance reported with sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy. The CADscore system operates with 3 intervals of risk stratification: \<20, 20-30, \>30 (low, intermedia and high risk of cardio vascular disease, respectively) Obstructive CAD is defined as ≥ 50% diameter stenosis as determined by quantitative analysis of CCA (QCA). Non-Obstructive CAD is defined as no detection of obstructive anatomic coronary artery stenosis by CCTA or stenosis detected by CCTA combined with a evaluation by CCA-QCA demonstrating a luminal stenosis diameter \< 50 %.

Secondary Outcome Measures

Name	Time	Method
Safety of CADScore Safety of CADScore	One week after the use of CADScore	Registration of adverse events related to the use of CADScore
Diagnostic accuracy of the CADScore system compared to CCA-FFR.	Within four weeks after CADScore	Diagnostic precision will be evaluated as the AUC-ROC and performance reported with sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy.; CAD is defined as CCA-FFR under 0.80.

Trial Locations

Locations (3)

Regional Hospital of Herning; 🇩🇰 Herning, Region Midtjylland, Denmark

Aarhus University Hospital; 🇩🇰 Aarhus, Region Midtjylland, Denmark

Regional Hospital of Silkeborg; 🇩🇰 Silkeborg, Region Midtjylland, Denmark